News from par pharmaceutical companies, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Nov 12, 2014, 07:30 ET

Par Pharmaceutical Announces First FDA Approval of Vasostrict™ (vasopressin injection, USP)

 Par Pharmaceutical Companies, Inc. today announced that it has received approval for its New Drug Application (NDA) for Vasostrict™...

Nov 06, 2014, 08:30 ET

Par Pharmaceutical Announces Quarterly Conference Call

 Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Thursday, November 13, 2014 at 9:00 a.m. EST to...

Sep 30, 2014, 07:30 ET

Par Pharmaceutical Begins Shipment of Generic Exforge®

 Par Pharmaceutical Companies, Inc. today announced that it has begun shipping all four strengths of amlodipine and valsartan tablets, the...

Sep 08, 2014, 12:24 ET

Par Pharmaceutical Resumes Shipment of Generic Precedex® Injection

Par Pharmaceutical Companies, Inc. today announced that it has resumed shipping dexmedetomidine hydrochloride (HCl) injection, EQ 100 mcg base/mL,...

Aug 06, 2014, 10:54 ET

Par Pharmaceutical Announces Quarterly Conference Call

Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Wednesday, August 13, 2014 at 10:00 a.m. EDT to review...

Jul 09, 2014, 08:00 ET

Par Pharmaceutical Begins Shipment of Fluphenazine Decanoate Injection, USP

Par Pharmaceutical Companies, Inc. today announced that it has received final approval from the U.S. Food and Drug Administration for its...

Jun 10, 2014, 14:34 ET

Strativa Pharmaceuticals Announces FDA Approval of Nascobal® (Cyanocobalamin, USP) Nasal Spray Single-Use Device

 Strativa Pharmaceuticals, the branded division of Par Pharmaceutical Companies, Inc., today announced that the U.S. Food and Drug...

May 07, 2014, 11:34 ET

Par Pharmaceutical Announces Quarterly Conference Call

Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Friday, May 16, 2014 at 9:30 a.m. EDT to review its...

Apr 07, 2014, 10:08 ET

Par Pharmaceutical Begins Shipment of Potassium Chloride Extended-Release Capsules

WOODCLIFF LAKE, N.J., April 7, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that it has received final approval from the...

Apr 01, 2014, 08:30 ET

Par Pharmaceutical Names Terrance J. Coughlin Chief Operating Officer

 Par Pharmaceutical Companies, Inc. today announced that Terrance J. Coughlin has been named chief operating officer.  In this capacity,...

Mar 13, 2014, 13:33 ET

Par Pharmaceutical Announces Fourth Quarter and Full Year 2013 Conference Call

 Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Thursday, March 20, 2014 at 10:00 a.m. EDT to...

Jan 21, 2014, 07:00 ET

Par Pharmaceutical to Acquire JHP Pharmaceuticals

 Par Pharmaceutical Companies, Inc. ("Par") today announced  that it has entered into a definitive agreement to acquire JHP Group...

Jan 16, 2014, 14:03 ET

Par Pharmaceutical Begins Shipment of Generic Lanoxin®

 Par Pharmaceutical Companies, Inc. today announced that it has entered into an exclusive U.S. supply and distribution...

Nov 20, 2013, 09:00 ET

Par Pharmaceutical Begins Shipment of Generic Focalin XR® Capsules

 Par Pharmaceutical Companies, Inc. today announced that it has begun shipping dexmethylphenidate hydrochloride (HCl) 15 mg and 30 mg...

Nov 05, 2013, 09:03 ET

Par Pharmaceutical Announces Quarterly Conference Call

 Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Wednesday, November 13, 2013, at 2:30 p.m. EST to...

Oct 24, 2013, 15:55 ET

Par Pharmaceutical's Karen O'Connor Receives 2013 Cardinal Health Supply Chain Excellence Award

Par Pharmaceutical Companies, Inc. is proud to announce that Karen O'Connor, vice president, national accounts, has received the generic...

Oct 07, 2013, 09:00 ET

Par Pharmaceutical Begins Shipment of Generic Kapvay®

Par Pharmaceutical Companies, Inc. today announced that it has received final approval from the U.S. Food and Drug Administration for its...

Sep 25, 2013, 09:00 ET

Par Pharmaceutical Begins Shipment of Generic Glucotrol XL®

 Par Pharmaceutical Companies, Inc. today announced that it has received final approval from the U.S. Food and Drug Administration for its...

Sep 23, 2013, 09:00 ET

Par Pharmaceutical Begins Shipment of KHEDEZLA (desvenlafaxine) Extended-release Tablets, 50 mg and 100 mg

 Par Pharmaceutical Companies, Inc. today announced that it has begun shipping KHEDEZLA (desvenlafaxine) Extended-release (ER) Tablets, 50 mg...

Aug 20, 2013, 09:09 ET

Par Pharmaceutical Receives Approval of sANDA for Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg

Par Pharmaceutical Companies, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its...